Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Obstetrics and Gynecology, Kaiser-Permanente, Los Angeles Medical Center, Los Angeles, California.
Fertil Steril. 2019 Apr;111(4):629-640. doi: 10.1016/j.fertnstert.2019.02.008.
Endometrial polyps, adenomyosis, and leiomyomas are commonly encountered abnormalities frequently found in both fertile women and those with infertility. The clinician is frequently challenged to determine which of these entities, when found, is likely to impair fertility, and which are "innocent bystanders" unrelated to the problem at hand. Although removing an endometrial polyp may be seen as a relatively benign and safe intervention, myomectomy, and in particular adenomyomectomy, can be substantive surgical procedures, associated with their own potential for disrupting fertility. One of the mechanisms thought to be involved when these entities are contributing to infertility is an adverse impact on endometrial receptivity. Indeed polyps, adenomyosis, and leiomyomas have all been associated with an increased likelihood of abnormal endometrial molecular expressions thought to impair implantation and early embryo development. This review is designed to examine the relationship of these common entities to endometrial receptivity and to identify evidence gaps that should be considered when strategizing research initiatives. It is apparent that we have the tools necessary to fill these gaps, but it will be necessary to approach the issue in a strategic and coordinated fashion. It is likely that we will have to recognize the limitations of imaging alone and look to the evidence-based addition of molecular analysis to provide the individualized phenotyping of disease necessary for patient-specific treatment decisions.
子宫内膜息肉、子宫腺肌病和子宫肌瘤是常见的异常情况,在有生育能力的女性和不孕女性中都很常见。临床医生经常面临的挑战是确定这些病变中,哪些在发现时可能会损害生育能力,哪些是与当前问题无关的“无辜旁观者”。虽然切除子宫内膜息肉可能被视为相对良性和安全的干预措施,但子宫肌瘤切除术,特别是腺肌瘤切除术,可能是实质性的手术,存在破坏生育能力的潜在风险。这些病变导致不孕的机制之一被认为是对子宫内膜容受性的不利影响。事实上,息肉、子宫腺肌病和子宫肌瘤都与子宫内膜分子表达异常的可能性增加有关,这些异常被认为会损害着床和早期胚胎发育。本综述旨在探讨这些常见病变与子宫内膜容受性的关系,并确定在制定研究计划时应考虑的证据空白。显然,我们已经具备了填补这些空白的必要工具,但必须以战略性和协调的方式来处理这个问题。很可能我们需要认识到仅依靠影像学的局限性,并寻求基于证据的分子分析的补充,以提供必要的个体化疾病表型,为患者的个体化治疗决策提供依据。